Autoantibody Detection

Blood autoantibodies sometimes target the body's own tissues which results in inflammation and organ damage. By measuring these antibodies scientists can evaluate both the immune health status of a person and detect possible autoimmune diseases. Early and precise detection improves disease diagnosis rates significantly and provides critical guidance for personalized treatment.

Autoantibodies often function as early indicators for autoimmune diseases which include systemic lupus erythematosus (SLE) and rheumatoid arthritis. Key clinical applications include:

• Early Diagnosis: Autoantibodies appear in more than half of patients who will develop autoimmune diseases prior to symptom emergence which allows for early medical intervention.
• Disease Subtyping: Autoantibody profiling identifies different disease subtypes by detecting markers like anti-dsDNA for SLE and anti-SS-A/Ro for Sjögren's syndrome.
• Treatment Monitoring: Longitudinal tracking of antibody levels helps evaluate responses to immunosuppressive therapies.